نتائج البحث - Minhee Won

تنقيح النتائج
  1. 1
    The patterns of care outcome study for cancer of the uterine cervix results of the second national practice survey

    The patterns of care outcome study for cancer of the uterine cervix results of the second national practice survey حسب L. Coia, Minhee Won, Rachelle Lanciano, Víctor A. Marcial, Karen Martz, G. Hanks

    منشور في 1990
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Validation and Simplification of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification for Glioblastoma

    Validation and Simplification of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification for Glioblastoma حسب Jing Li, Meihua Wang, Minhee Won, Edward G. Shaw, Christopher T. Coughlin, Walter J. Curran, Minesh P. Mehta

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology Group Database

    Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology Group Database حسب Deborah T. Blumenthal, Minhee Won, Minesh P. Mehta, Walter J. Curran, Luís Souhami, Jeff M. Michalski, Leland Rogers, Benjamin W. Corn

    منشور في 2008
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

    RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma حسب Prakash Chinnaiyan, Minhee Won, Patrick Y. Wen, Amyn M. Rojiani, Merideth M Wendland, Thomas A. DiPetrillo, Benjamin W. Corn, Minesh P. Mehta

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole-Brain Radiation Therapy Versus WBRT Plus Stereotactic Radiosurgery in Patients With 1-3 Brain Metastases; Poststratified by the Graded Prognostic Assessment (GPA)

    Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole-Brain Radiation Therapy Versus WBRT Plus Stereotactic Radiosurgery in Patients With 1-3 Brain Metastases; Posts... حسب Paul W. Sperduto, Ryan Shanley, Xianghua Luo, David W. Andrews, Maria Werner‐Wasik, Richard K. Valicenti, Jean-Paul Bahary, Luís Souhami, Minhee Won, Minesh P. Mehta

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

    Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients... حسب Terri S. Armstrong, Jeffrey S. Wefel, Meihua Wang, Mark R. Gilbert, Minhee Won, Andrew Bottomley, Tito R. Mendoza, Corneel Coens, Maria Werner‐Wasik, David Brachman, Ali Choucair, Minesh P. Mehta

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Effect of the Addition of Chemotherapy to Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma: Secondary Analysis of RTOG 98-02

    Effect of the Addition of Chemotherapy to Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma: Secondary Analysis of RTOG 98-02 حسب Roshan S. Prabhu, Minhee Won, Edward G. Shaw, Chen Hu, David Brachman, Jan C. Buckner, K. Stelzer, Geoffrey R. Barger, Paul D. Brown, Mark R. Gilbert, Minesh P. Mehta

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)

    Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627) حسب Andrew B. Lassman, Stephanie L. Pugh, Mark R. Gilbert, Kenneth Aldape, Sandrine Geinoz, Jan H. Beumer, Susan M. Christner, Ritsuko Komaki, Lisa M. DeAngelis, Rakesh Gaur, Emad Youssef, Henry Wagner, Minhee Won, Minesh P. Mehta

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227

    Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS... حسب Jon Glass, Minhee Won, Christopher J. Schultz, Daniel J. Brat, Nancy L. Bartlett, John H. Suh, Maria Werner‐Wasik, Barbara J. Fisher, Marcia K. Liepman, Mark E. Augspurger, Felix Bokstein, Joseph Bovi, Matthew C. Solhjem, Minesh P. Mehta

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913

    A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913 حسب Prakash Chinnaiyan, Minhee Won, Patrick Y. Wen, Amyn M. Rojiani, Maria Werner‐Wasik, Helen A. Shih, Lynn S. Ashby, Ya-Yu Tsai, Volker W. Stieber, Shawn Malone, John B. Fiveash, Nimish Mohile, Manmeet S. Ahluwalia, Merideth M Wendland, Philip J. Stella, Andrew Y. Kee, Minesh P. Mehta

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

    Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial حسب Mark R. Gilbert, Meihua Wang, Kenneth Aldape, Roger Stupp, Monika E. Hegi, Kurt A. Jaeckle, Terri S. Armstrong, Jeffrey S. Wefel, Minhee Won, Deborah T. Blumenthal, Anita Mahajan, Christopher J. Schultz, Sara Erridge, Brigitta G. Baumert, Kristen I. Hopkins, Tzahala Tzuk-Shina, Paul D. Brown, Arnab Chakravarti, Walter J. Curran, Minesh P. Mehta

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539

    High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539 حسب Leland Rogers, Minhee Won, Michael A. Vogelbaum, Arie Perry, Lynn S. Ashby, Jignesh Modi, Anthony M. Alleman, James M. Galvin, Shannon Fogh, Emad Youssef, Nimisha Deb, Young Kwok, Clifford G. Robinson, Hui‐Kuo G. Shu, Barbara J. Fisher, Valérie Panet-Raymond, W. G. McMillan, John de Groot, Peixin Zhang, Minesh P. Mehta

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539

    Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539 حسب Leland Rogers, Stephanie L. Pugh, Michael A. Vogelbaum, Arie Perry, Lynn S. Ashby, Jignesh Modi, Anthony M. Alleman, Igor J. Barani, Steve Braunstein, Joseph Bovi, John de Groot, Anthony Whitton, Scott Lindhorst, Nimisha Deb, Dennis C. Shrieve, Hui‐Kuo G. Shu, Beatrice Bloom, Mitchell Machtay, Mark V. Mishra, Clifford G. Robinson, Minhee Won, Minesh P. Mehta

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

    A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma حسب Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, Jeffrey S. Wefel, Deborah T. Blumenthal, Michael A. Vogelbaum, Howard Colman, Arnab Chakravarti, Stephanie L. Pugh, Minhee Won, Robert Jeraj, Paul D. Brown, Kurt A. Jaeckle, David Schiff, Volker W. Stieber, David Brachman, Maria Werner‐Wasik, Ivo W. Tremont‐Lukats, Erik P. Sulman, Kenneth Aldape, Walter J. Curran, Minesh P. Mehta

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424

    Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424 حسب Barbara J. Fisher, Stephanie L. Pugh, David Macdonald, Arnab Chakravatri, Glenn J. Lesser, Sherry Fox, Leland Rogers, Maria Werner‐Wasik, Thomas J. Doyle, Jean-Paul Bahary, John B. Fiveash, Joseph Bovi, Steven Howard, Ya-Yu Tsai, David D’Souza, Nadia N. Laack, Igor J. Barani, Young Kwok, Daniel Wahl, Jon Strasser, Minhee Won, Minesh P. Mehta

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors

    Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors حسب Andrew B. Lassman, Khê Hoang‐Xuan, Mei‐Yin C. Polley, Alba A. Brandes, J. Gregory Cairncross, Johan M. Kros, Lynn S. Ashby, Martin Taphoorn, Luís Souhami, Winand N.M. Dinjens, Nadia N. Laack, Mathilde C.M. Kouwenhoven, Karen Fink, Pim J. French, David R. Macdonald, Denis Lacombe, Minhee Won, Thierry Gorlia, Minesh P. Mehta, Martin J. van den Bent

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

    Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma حسب Jan C. Buckner, Edward G. Shaw, Stephanie L. Pugh, Arnab Chakravarti, Mark R. Gilbert, Geoffrey R. Barger, Stephen W. Coons, Peter E. Ricci, Dennis E. Bullard, Paul D. Brown, K. Stelzer, David Brachman, John H. Suh, Christopher J. Schultz, Jean-Paul Bahary, Barbara J. Fisher, Harold Kim, Albert Murtha, Erica H. Bell, Minhee Won, Minesh P. Mehta, Walter J. Curran

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era

    Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era حسب Erica H. Bell, Stephanie L. Pugh, Joseph P. McElroy, Mark R. Gilbert, Minesh P. Mehta, Alexander C. Klimowicz, Anthony M. Magliocco, Markus Bredel, Pierre A. Robe, Anca‐L. Grosu, Roger Stupp, Walter J. Curran, Aline Paixão Becker, Andrea L. Salavaggione, Jill S. Barnholtz‐Sloan, Kenneth Aldape, Deborah T. Blumenthal, Paul D. Brown, Jon Glass, Luís Souhami, R. Jeffrey Lee, David Brachman, John C. Flíckinger, Minhee Won, Arnab Chakravarti

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

    Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grad... حسب Erica H. Bell, Peixin Zhang, Edward G. Shaw, Jan C. Buckner, Geoffrey R. Barger, Dennis E. Bullard, Minesh P. Mehta, Mark R. Gilbert, Paul D. Brown, K. Stelzer, Joseph P. McElroy, Jessica L. Fleming, Cynthia Timmers, Aline Paixão Becker, Andrea L. Salavaggione, Ziyan Liu, Kenneth Aldape, David Brachman, Stanley Z. Gertler, Albert Murtha, Christopher J. Schultz, David W. Johnson, Nadia N. Laack, G.K. Hunter, Ian Crocker, Minhee Won, Arnab Chakravarti

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

    Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial حسب Andrew B. Lassman, Stephanie L. Pugh, Tony J. C. Wang, Kenneth Aldape, Hui Gan, Matthias Preusser, Michael A. Vogelbaum, Erik P. Sulman, Minhee Won, Peixin Zhang, Golnaz Moazami, Marian S. Macsai, Mark R. Gilbert, Earle Bain, Vincent Blot, Peter Ansell, Suvajit Samanta, Madan G. Kundu, Terri S. Armstrong, Jeffrey S. Wefel, Clemens Seidel, Filip De Vos, Sigmund Hsu, Andrés F. Cardona, Giuseppe Lombardi, Dmitry Bentsion, Richard A. Peterson, Craig Gedye, Véronique Bourg, Antje Wick, Walter J. Curran, Minesh P. Mehta

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: